Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

6.23
+0.26574.45%
Volume:560.36K
Turnover:3.41M
Market Cap:3.41M
PE:-0.06
High:6.79
Open:6.06
Low:5.34
Close:5.96
52wk High:249.75
52wk Low:4.68
Shares:547.78K
Float Shares:547.42K
Volume Ratio:0.87
T/O Rate:102.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-102.4149
EPS(LYR):-337.9329
ROE:-705.71%
ROA:-127.92%
PB:0.68
PE(LYR):-0.02

Loading ...

Artelo Biosciences Inc trading halted, news pending

TIPRANKS
·
Aug 29

Artelo Biosciences Announces Reverse Stock Split

THOMSON REUTERS
·
Aug 27

Artelo secures Japan patent allowance for ART27.13 commercial formulation

TIPRANKS
·
Aug 20

Artelo Biosciences Wins Japan Patent Allowance for Art27.13 Commercial Formulation

Reuters
·
Aug 20

Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of Art27.13

THOMSON REUTERS
·
Aug 20

Artelo Biosciences - Art27.13 Patent Estate Issued or Allowed in US, Japan, Europe

THOMSON REUTERS
·
Aug 20

Artelo Biosciences - Receives Uspto Notice of Allowance for Art27.13 Formulation Patent

THOMSON REUTERS
·
Aug 17

Artelo Biosciences - Patent Protection for Art27.13 Expected Through 2041

THOMSON REUTERS
·
Aug 17

Artelo Biosciences Gets USPTO Notice of Allowance for Art27.13 Formulation Patent Application

Reuters
·
Aug 17

Equillium Q2 Post Narrower Net Loss than Expected; Starts R&D Initiatives

Reuters
·
Aug 14

Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 14

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Reuters
·
Aug 14

CV Sciences Q2 Sales Fall on Regulatory Pressure

Reuters
·
Aug 14

Artelo Biosciences Q2 EPS $(0.89) Up From $(16.83) YoY

Benzinga Earnings
·
Aug 13

Artelo Biosciences Q2 EPS USD -0.89

THOMSON REUTERS
·
Aug 13

Press Release: Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

Dow Jones
·
Aug 13

Artelo Biosciences Q2 FY26 Net Loss Narrows 24.65% to USD 2.43 Million

Reuters
·
Aug 13

Artelo Biosciences Doses First Patient in Phase 2 Glaucoma Trial of Art27.13

Reuters
·
Aug 10

Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating Art27.13 for Treatment of Glaucoma

THOMSON REUTERS
·
Aug 10

Artelo Biosciences - Initial Dream Study Results Anticipated in Q4 2026

THOMSON REUTERS
·
Aug 10